|
Sep 10
|
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
|
|
Sep 5
|
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024
|
|
Sep 4
|
SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024
|
|
Jul 29
|
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™
|
|
Jul 24
|
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix
|
|
Jun 24
|
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting
|
|
Jun 24
|
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application
|
|
May 13
|
SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript
|
|
May 8
|
SOPHiA GENETICS First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 7
|
Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a Bet
|
|
May 7
|
SOPHiA GENETICS Reports First Quarter 2024 Results
|
|
Apr 30
|
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
|
|
Apr 23
|
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
|
|
Apr 23
|
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
|
|
Apr 21
|
We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
|
|
Apr 17
|
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
|
|
Apr 4
|
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
|
|
Apr 2
|
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™
|
|
Mar 20
|
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
|
|
Mar 15
|
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
|